Microbiome Therapeutics Market Analysis

Application {Diabetes, Crohn’s Disease, Clostridium Difficile Infection (CDI), Multiple Sclerosis, Rheumatoid Arthritis, and Others}

The global microbiome therapeutics market is segmented and analyzed for demand and supply by application into diabetes, crohn’s disease, clostridium difficile infection (CDI), multiple sclerosis, rheumatoid arthritis, and others. Out of these segments, the diabetes segment is estimated to gain the largest market share of about 30% in the year 2037. The growth of the segment can be attributed to the increasing prevalence of diabetes around the globe, coupled with the growing research and developments on the use of microbiome therapeutics for curing type 2 diabetes. According to the statistics by the Centers for Disease Control and Prevention (CDC), by the year 2022, around 37.3 million of the population of the United States had diabetes. Studies have reflected that gut bacteria play a fundamental role in diseases such as diabetes, especially type 2 diabetes. Type 2 diabetes is largely undiagnosed and is caused as of excessive body weight and physical inactivity. Research on the first human metagenome demonstrated the correlation between certain bacterial genes, specific intestinal bacteria, and their respective metabolic pathways with type 2 diabetes (T2D).

Product (Prebiotics, Probiotics, Symbiotics, and Others)

The global microbiome therapeutics market is also segmented and analyzed for demand and supply by product into prebiotics, probiotics, symbiotics, and others. Amongst these four segments, the probiotics segment is expected to garner a significant share of about 40% in the year 2037. The growth of the segment can be attributed to the significant advantages of probiotics in the improvement of intestinal health, coupled with the improvement of lactose intolerance symptoms and the decrease of the risk of numerous other diseases. Probiotics are live good bacteria or yeasts that naturally exist in our body and are hugely advantageous for gut health. They aid in the maintenance of a healthy microorganism community in our body. Hence, currently, individuals are inclined to take probiotics for the benefit of digestive health. For instance, based on a consumer survey report, nearly 1/3 of individuals in the United States were keenly trying to consume probiotics, out of which around 61% were trying to use them on daily basis, and around 26% were trying to consume them several times within a day. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments: